C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2004
12/29/2004	WO2004113872A2 Covalent methods for immobilization of thiolated biomolecules on siliceous and metallic surfaces
12/29/2004	WO2004113574A2 Methods for disease screening
12/29/2004	WO2004113572A1 Composition for screening anti-hypertension drug comprising mammal tctp gene or its protein product, and method for screening anti-hypertension drug using said composition
12/29/2004	WO2004113571A2 Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis
12/29/2004	WO2004113570A2 Genotype test for dogs
12/29/2004	WO2004113569A2 Methods for preparing gene chips and use thereof
12/29/2004	WO2004113568A2 Methods for the diagnosis and prognosis of alzheimer's disease
12/29/2004	WO2004113567A2 Improved heavymethyl assay for the methylation analysis of the gstpi gene
12/29/2004	WO2004113565A1 Method of producing recombinant dna molecules
12/29/2004	WO2004113564A1 Method for investigating cytosine methylation in dna sequences by means of triplex-forming oligomers
12/29/2004	WO2004113563A2 Probes, libraries and kits for analysis of mixtures of nucleic acids and methods for constructing the same
12/29/2004	WO2004113562A1 Method for assaying lkb1 phosphorylation activity
12/29/2004	WO2004113560A1 In vivo test system for detecting hiv-protease activity
12/29/2004	WO2004113559A1 Method for the decomposition and derivatization of biological samples and method for detecting bacteria in said samples
12/29/2004	WO2004113557A2 Methods and systems for the analysis of biological sequence data
12/29/2004	WO2004113556A2 Assay and kits for detecting protein binding
12/29/2004	WO2004113555A2 Identifying, monitoring, and sorting genetically modified plant portions
12/29/2004	WO2004113554A2 Methods for determining susceptibility to psoriasis
12/29/2004	WO2004113534A1 Method for producing a synthetic gene or other dna sequence
12/29/2004	WO2004113529A1 Method of detecting reaction between dna and dna binding proteins
12/29/2004	WO2004113526A1 Method of preparing gene expression profile
12/29/2004	WO2004113523A1 Granzyme b/golgin-160 interaction inhibitor
12/29/2004	WO2004113522A1 New biological entities and the pharmaceutical or diagnostic use thereof
12/29/2004	WO2004113521A1 New biological entities and the use thereof
12/29/2004	WO2004113515A2 Tissue modeling in embryonic stem (es) cell system
12/29/2004	WO2004113502A2 Identification of therapeutic agents using genetic fingerprinting
12/29/2004	WO2004113498A2 Rna interferases and methods of use thereof
12/29/2004	WO2004112829A2 Compositions and methods for the diagnosis and treatment of tumors of glial origin
12/29/2004	WO2004112763A2 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure
12/29/2004	WO2004112730A2 Method and compositions for treating tumors
12/29/2004	WO2004112726A2 Methods and compositions for controlling appetite and modulating insulin sensitivity
12/29/2004	WO2004112698A2 Methods for obtaining anti-retroviral agents
12/29/2004	WO2004112589A2 Method for the detection of gene transcripts in blood and uses thereof
12/29/2004	WO2004112575A2 Gene amplification and overexpression in cancer
12/29/2004	WO2004112572A2 Monitoring immunologic, hematologic and inflammatory diseases
12/29/2004	WO2004112570A2 Detection of survivin in the biological fluids of cancer patients
12/29/2004	WO2004096999A3 In vitro translation system
12/29/2004	WO2004094660A3 Use of gene dpysl3 as a marker of psoriasis
12/29/2004	WO2004090150A3 Pcr method using multiple primer pairs and the solution used in it and the use of the method in the detection reagents
12/29/2004	WO2004076657A3 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
12/29/2004	WO2004072244A3 Polymerase-based protocols for generating chimeric oligonucleotides
12/29/2004	WO2004065542A3 MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/29/2004	WO2004063353A3 Method of detecting dna single strand breaks
12/29/2004	WO2004061410A3 Serum biomarkers in lung cancer
12/29/2004	WO2004046332A3 Amplified genes involved in cancer
12/29/2004	WO2004042083A3 Nucleic acid ligands and uses therefor
12/29/2004	WO2004039309A3 Dc-sign isoforms, related compositions and methods for their use in disease therapy
12/29/2004	WO2004035741A3 Susceptibility gene for myocardial infarction; methods of treatment
12/29/2004	WO2004020998A8 Evaluation method for predicting pharmacokinetics of pm using pm liver cells of drug metabolizing enzyme cytochrome p450 having a genetic polymorphism
12/29/2004	WO2004015072A3 Mrbs as modifiers of the rb pathway and methods of use
12/29/2004	WO2004008480A3 Quantitative analysis via isotopically differentitated derivatization
12/29/2004	WO2004005481A3 Methods for identifying modulators of mda-7 mediated apoptosis
12/29/2004	WO2004001014A3 Osteopontin, oligodendrocytes and myelination
12/29/2004	WO2003093797A3 Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids
12/29/2004	WO2003068983A9 Use of the axl receptor for diagnosis and treatment of renal disease
12/29/2004	WO2003060162A8 Method of specifying snp
12/29/2004	WO2003057178A3 Viral capsid assembly intermediates
12/29/2004	WO2003057146A3 Novel compositions and methods for cancer
12/29/2004	WO2003050289A8 Method for detecting microorganisms
12/29/2004	WO2003045984A3 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
12/29/2004	WO2003010336A3 Molecular markers for hepatocellular carcinoma
12/29/2004	WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer
12/29/2004	WO2000061774A3 Bone morphogenic proteins
12/29/2004	EP1492172A1 Microelectronic components and electronic networks comprising DNA
12/29/2004	EP1492043A2 Pharmacophore model generation and use
12/29/2004	EP1491894A2 Method for the determination of cell activation
12/29/2004	EP1491639A2 Method of analyzing cytosin methylation status of cancer-testis-antigens for individualised immunotherapy
12/29/2004	EP1491638A2 Apparatus and method for nucleic acid spatial ordering
12/29/2004	EP1491637A1 Process for improving efficiency of DNA amplification reactions
12/29/2004	EP1491636A1 Method of detecting mild impaired glucose tolerance or insulin hyposecretion
12/29/2004	EP1491635A2 Reagentless biosensor for the determination of nitriles and cyanides
12/29/2004	EP1491630A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor
12/29/2004	EP1491629A1 Novel method of highly sensitive nucleic acid analysis
12/29/2004	EP1491628A1 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
12/29/2004	EP1491627A1 Gene examination method for judging the onset risk of glaucoma
12/29/2004	EP1491626A1 Method of assaying target nucleic acid and kit therefor
12/29/2004	EP1491555A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
12/29/2004	EP1491505A1 Method of measuring and controlling the formation of biofilms in a watersystem
12/29/2004	EP1491217A1 Stabilization of polynucleotide complexes
12/29/2004	EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/29/2004	EP1491089A1 Media comprising gellan gum and methods for promoting maturation of conifer somatic embryos
12/29/2004	EP1490887A2 Microscale sensor element and related device and method of manufacture
12/29/2004	EP1490826A2 Methods of evaluating dna-based links
12/29/2004	EP1490824A2 Method and system for determining absolute mrna quantities
12/29/2004	EP1490823A1 A method for gene mapping from genotype and phenotype data
12/29/2004	EP1490768A1 Adaptive behavioral intrusion detection systems and methods
12/29/2004	EP1490697A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1)
12/29/2004	EP1490696A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
12/29/2004	EP1490694A1 Camp-regulated phosphorprotein for diagnostic and therapeutic use in neurodegenerative diseases
12/29/2004	EP1490693A1 Method for characterising analytes
12/29/2004	EP1490692A2 Diagnostic and therapeutic use of caps
12/29/2004	EP1490691A2 Luminescent, spheroid, non-autofluorescent silica gel particles having variable emission intensities and frequencies
12/29/2004	EP1490690A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
12/29/2004	EP1490689A1 Novel compositions and methods in cancer associated with altered expression of prlr
12/29/2004	EP1490688A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
12/29/2004	EP1490687A1 Methods for detecting ovarian cancer
12/29/2004	EP1490686A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
12/29/2004	EP1490682A1 Detection of dna-binding proteins
12/29/2004	EP1490681A2 Peptide screen
12/29/2004	EP1490674A1 Biosensor for purines

1 ... 1811 1812 1813 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 ... 3003